Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Depakine Injectable


Contraindicated
Risk of congenital malformations and neuro-developmental disorders

Contraindicated
Hematologic disorders in breastfed newborns
Depakine Injectable :
Type Medicine Authorised
Originator B
Agent Mersaco
Distributor Mersaco
Laboratory Sanofi
Responsible Party Sanofi Aventis
Origin France
Manufacturer Sanofi SpA
Origin Italy
ATC N03AG01

Your comment will appear shortly after approval

Depakine Injectable :

Revision Date : 05/12/2016


Effect Frequency
Abnormal behaviour Rare
Acne Uncommon
Activated partial thromboplastin time prolonged Rare
Aggressiveness Common
Agitation Common
Agranulocytosis Rare
Amenorrhoea (amenorrhea) Uncommon
Anaemia Common
Anaemia macrocytic Rare
Androgenetic alopecia Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Ataxia Uncommon
Biotinidase deficiency Rare
Birth defects (Foetal malformation) Not known
Bone density decreased Uncommon
Bone marrow failure (Myelosuppression) Rare
Cephalea Common
Coagulation factor deficiency Rare
Coagulation test abnormal Rare
Cognitive disorder Rare
Coma Uncommon
Confusional state Common
Convulsion Common
Convulsions aggravated Uncommon
Dementia Rare
Diarrhoea (Diarrhea) Common
Dizziness Common
DRESS (Drug reaction with eosinophilia and systemic symptoms) Rare
Drug hypersensitivity Rare
Encephalopathy Uncommon
Enuresis Rare
Epigastralgia (Epigastric pain) Common
Erythema multiforme Rare
Extrapyramidal disorder Common
Fracture Uncommon
Gingival disorder Common
Gingival hyperplasia Common
Haemorrhage Common
Hair colour changes Uncommon
Hair growth abnormal Uncommon
Hair loss Common
Hair texture abnormal Uncommon
Hallucination Common
Hearing loss Common
Hepatopathy Common
Hirsutism Uncommon
Hyperammonaemia Rare
Hyperandrogenaemia Uncommon
Hyponatraemia (Hyponatremia) Common
Hypothermia Uncommon
Hypothyroidism Rare
Impairment of attention Common
Inappropriate antidiuretic hormone secretion (SIADH) Uncommon
INR increased Rare
Learning disability Rare
Lethargy Uncommon
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Rare
Macrocytosis Rare
Memory impairment Common
Menstrual disorder Common
Myelodysplastic syndrome Rare
Nail bed disorder Common
Nail disorders Common
Nausea Very Common
Nystagmus Common
Obesity Rare
Oedema peripheral Uncommon
Osteopenia Uncommon
Osteoporosis Uncommon
Pancreatitis Uncommon
Pancytopenia Uncommon
Paraesthesia (paresthesia) Uncommon
Parkinsonism Uncommon
Pleural effusion Uncommon
Polycystic ovaries Rare
Prothrombin time prolonged Rare
Psychomotor hyperactivity (Psychomotor restlessness) Rare
Red cell aplasia Rare
Renal insufficiency Uncommon
Rhabdomyolysis Rare
Sedation Common
Shakiness Very Common
Skin reaction Uncommon
Spermatogenesis abnormal Rare
Spermatozoa progressive motility decreased Rare
Stevens-Johnson syndrome Rare
Stomatitis Common
Stupor Common
Systemic lupus erythematosus Rare
Thrombocytopenic hemorrhage Common
Tubulointerstitial nephritis Rare
Urinary incontinence Rare
Virilism Uncommon
Vomiting Common
Weight increased (weight gain) Common

Different Units By MoH Code

Revision Date : 01/07/2018

Revision Date : 01/07/2015

Depakine Injectable Depakine Injectable Depakine Injectable Depakine Injectable Depakine Injectable Depakine Injectable

Depakine Injectable  MoH 2986 :
Form Powder and solvent for solution for injection
Packaging Vial + Ampoule
Package Size 1+1 diluent
Strength 400mg
Storage Condition <30°C None
Public Price 452702,25 L.L.
Stratum A1
NSSF ✔
Quarantine ✘
Reg. Number 973478/02
Submission date 01/01/2003
Registration Year 2003


NB : Pack size variation, from 4 to 1, on 20/03/2018

Price Comparison

● Country: Jordan
● Package Size: 1
● Public Price: 24.22 JOD ( 516,859.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 24,22 JOD ( 512,164.56 LBP )
● Pharmacy Price: 23.29 JOD ( 497013.0251 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder and solvent for solution for injection
● Package Size: 1+1 diluent
● Public Price: 452702.25 LBP ( 452,702.25 LBP )
● Pack size unit used: 1
● Cost/Unit: 452702,25 LBP ( 452,702.00 LBP )
● Pricing Date: 10/01/2024

● Country: The Netherlands
● Package Size: 1
● Public Price: 19.19 EUR ( 352,713.16 LBP )
● Pack size unit used: 1
● Cost/Unit: 19,19 EUR ( 349,220.95 LBP )
● Pharmacy Price: 12.19 EUR ( 224052.8095 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Finland
● Package Size: 4x(400 mg + 4ml)
● Public Price: 78.75 EUR ( 1,447,428.94 LBP )
● Pack size unit used: 4
● Cost/Unit: 19,6875 EUR ( 349,220.95 LBP )
● Reference: Kela
● Pricing Date: 13/03/2019
● Type: Medicine Authorised

● Country: UAE
● Package Size: 4 Vials (Dry) + 4 Solvent Ampoules (4ml)
● Public Price: 259.5 AED ( 1,066,794.12 LBP )
● Pack size unit used: 4
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Pharmacy Price: 208.92 AED ( 858861.7632 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 4 Vials + 4 Solvent Ampoules (4ml)
● Public Price: 259.5 AED ( 1,066,794.12 LBP )
● Pack size unit used: 4
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Pharmacy Price: 208.92 AED ( 858861.7632 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 4
● Public Price: 50.42 EUR ( 926,722.12 LBP )
● Pack size unit used: 4
● Cost/Unit: 12,605 EUR ( 220,560.60 LBP )
● Exfactory Price: 22.91 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Oman
● Package Size: 4+4x4ml
● Public Price: 22.95 OMR ( 901,946.48 LBP )
● Pack size unit used: 4
● Cost/Unit: 5,7375 OMR ( 196,502.50 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1x4ml
● Public Price: 10.36 EUR ( 190,417.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 10,36 EUR ( 183,800.50 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 4+4x4ml
● Public Price: 927.32 CZK ( 640,555.56 LBP )
● Pack size unit used: 4
● Cost/Unit: 231,83 CZK ( 159,565.56 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: KSA
● Package Size: 4
● Public Price: 128.35 SAR ( 517,299.27 LBP )
● Pack size unit used: 4
● Cost/Unit: 32,0875 SAR ( 128,972.16 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1+1
● Public Price: 5.91 EUR ( 108,626.10 LBP )
● Pack size unit used: 1
● Cost/Unit: 5,91 EUR ( 91,900.25 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 4+4x4ml
● Public Price: 12 EUR ( 220,560.60 LBP )
● Pack size unit used: 4
● Cost/Unit: 3 EUR ( 55,140.15 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: Turkey
● Package Size: 4
● Public Price: 65.04 TRY ( 124,921.68 LBP )
● Pack size unit used: 4
● Cost/Unit: 16,26 TRY ( 30,731.04 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Portugal
● Package Size: 4+4x4ml
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Generalized seizures : (Adults)
● Cost/Unit: 24,22 JOD ( 512,164.56 LBP )
● Cost/Day: 48,44 JOD ( 1,024,329.12 LBP )
● Cost/Month: 242,2 JOD ( 5,164,325.98 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 24,22 JOD ( 512,164.56 LBP )
● Cost/Day: 48,44 JOD ( 1,024,329.12 LBP )
● Cost/Month: 242,2 JOD ( 5,164,325.98 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 452702,25 LBP ( 452,702.00 LBP )
● Cost/Day: 905404,5 LBP ( 905,404.00 LBP )
● Cost/Month: 4527022,5 LBP ( 4,527,022.00 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 452702,25 LBP ( 452,702.00 LBP )
● Cost/Day: 905404,5 LBP ( 905,404.00 LBP )
● Cost/Month: 4527022,5 LBP ( 4,527,022.00 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 19,19 EUR ( 349,220.95 LBP )
● Cost/Day: 38,38 EUR ( 698,441.90 LBP )
● Cost/Month: 191,9 EUR ( 3,510,589.55 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 19,19 EUR ( 349,220.95 LBP )
● Cost/Day: 38,38 EUR ( 698,441.90 LBP )
● Cost/Month: 191,9 EUR ( 3,510,589.55 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 19,6875 EUR ( 349,220.95 LBP )
● Cost/Day: 39,38 EUR ( 716,821.95 LBP )
● Cost/Month: 196,9 EUR ( 3,602,489.80 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 19,6875 EUR ( 349,220.95 LBP )
● Cost/Day: 39,38 EUR ( 716,821.95 LBP )
● Cost/Month: 196,9 EUR ( 3,602,489.80 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Cost/Day: 129,75 AED ( 530,313.84 LBP )
● Cost/Month: 648,75 AED ( 2,663,902.08 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Cost/Day: 129,75 AED ( 530,313.84 LBP )
● Cost/Month: 648,75 AED ( 2,663,902.08 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Cost/Day: 129,75 AED ( 530,313.84 LBP )
● Cost/Month: 648,75 AED ( 2,663,902.08 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 64,875 AED ( 263,101.44 LBP )
● Cost/Day: 129,75 AED ( 530,313.84 LBP )
● Cost/Month: 648,75 AED ( 2,663,902.08 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 12,605 EUR ( 220,560.60 LBP )
● Cost/Day: 25,21 EUR ( 459,501.25 LBP )
● Cost/Month: 126,05 EUR ( 2,315,886.30 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 12,605 EUR ( 220,560.60 LBP )
● Cost/Day: 25,21 EUR ( 459,501.25 LBP )
● Cost/Month: 126,05 EUR ( 2,315,886.30 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 5,7375 OMR ( 196,502.50 LBP )
● Cost/Day: 11,48 OMR ( 432,305.50 LBP )
● Cost/Month: 57,4 OMR ( 2,240,128.50 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 5,7375 OMR ( 196,502.50 LBP )
● Cost/Day: 11,48 OMR ( 432,305.50 LBP )
● Cost/Month: 57,4 OMR ( 2,240,128.50 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 10,36 EUR ( 183,800.50 LBP )
● Cost/Day: 20,72 EUR ( 367,601.00 LBP )
● Cost/Month: 103,6 EUR ( 1,893,145.15 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 10,36 EUR ( 183,800.50 LBP )
● Cost/Day: 20,72 EUR ( 367,601.00 LBP )
● Cost/Month: 103,6 EUR ( 1,893,145.15 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 231,83 CZK ( 159,565.56 LBP )
● Cost/Day: 463,66 CZK ( 319,821.88 LBP )
● Cost/Month: 2318,3 CZK ( 1,601,181.68 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 231,83 CZK ( 159,565.56 LBP )
● Cost/Day: 463,66 CZK ( 319,821.88 LBP )
● Cost/Month: 2318,3 CZK ( 1,601,181.68 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 32,0875 SAR ( 128,972.16 LBP )
● Cost/Day: 64,18 SAR ( 257,944.32 LBP )
● Cost/Month: 320,9 SAR ( 1,289,721.60 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 32,0875 SAR ( 128,972.16 LBP )
● Cost/Day: 64,18 SAR ( 257,944.32 LBP )
● Cost/Month: 320,9 SAR ( 1,289,721.60 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 5,91 EUR ( 91,900.25 LBP )
● Cost/Day: 11,82 EUR ( 202,180.55 LBP )
● Cost/Month: 59,1 EUR ( 1,084,422.95 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 5,91 EUR ( 91,900.25 LBP )
● Cost/Day: 11,82 EUR ( 202,180.55 LBP )
● Cost/Month: 59,1 EUR ( 1,084,422.95 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 3 EUR ( 55,140.15 LBP )
● Cost/Day: 6 EUR ( 110,280.30 LBP )
● Cost/Month: 30 EUR ( 551,401.50 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 3 EUR ( 55,140.15 LBP )
● Cost/Day: 6 EUR ( 110,280.30 LBP )
● Cost/Month: 30 EUR ( 551,401.50 LBP )
Generalized seizures : (Adults)
● Cost/Unit: 16,26 TRY ( 30,731.04 LBP )
● Cost/Day: 32,52 TRY ( 61,462.08 LBP )
● Cost/Month: 162,6 TRY ( 311,151.78 LBP )
Secondarily generalised seizures : (Adults)
● Cost/Unit: 16,26 TRY ( 30,731.04 LBP )
● Cost/Day: 32,52 TRY ( 61,462.08 LBP )
● Cost/Month: 162,6 TRY ( 311,151.78 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info